Introduction
Although the primary targets of cytotoxic anticancer therapies comprise distinct intracellular structures, such as the nucleus, cell membrane, endoplasmic reticulum and cytoskeleton, considerable evidence exists that DNA damage or disruption of the spindle checkpoint ultimately triggers the activation of common apoptotic pathways (Rudner et al., 2001; Wieder et al., 2001; Gu¨ner et al., 2003; von Haefen et al., 2003) . To identify the signaling components being triggered by anticancer therapeutics, we have analysed the key steps of apoptosis execution, that is, activation of the mitochondrial apoptosis signaling cascade and the caspases. These analyses revealed that disruption of downstream cell death signaling molecules is closely related to resistance to chemotherapeutic agents and irradiation. Thus, loss of Bax (Sturm et al., , 2001 Mrozek et al., 2003) , overexpression of Bcl-2 (Radetzki et al., 2002; von Haefen et al., 2003; Klo¨pfer et al., 2004) and disturbance of caspase activation (Prokop et al., 2000; Friedrich et al., 2001 ) have all been implicated in resistance mechanisms, ultimately resulting in failure of anticancer therapies not only in cell line models but also in the clinical setting.
To overcome such constitutive or acquired resistance mechanisms and to show the functional relevance of such signaling defects, we reconstituted key components of the apoptosis signaling transduction machinery. The expression of proapoptotic Bcl-2 family members such as Bax (Hemmati et al., 2002; von Haefen et al., 2002 von Haefen et al., , 2004 , Bak and Nbk/Bik (Radetzki et al., 2002; von Haefen et al., 2004) , reverted drug resistance not only in cells resistant due to loss of Bax or overexpression of Bcl-2 but also in cells overexpressing P-glycoprotein/ Mdr-1. Furthermore, we demonstrated that MCF-7 cells have lost caspase-3 expression in consequence of a 47-base pair deletion within exon 3 of the CASP-3 gene and show a profound defect in activating the apoptosis execution machinery upon exposure to chemotherapeutic drugs such as anthracyclines, etoposide and taxol.
Reconstitution of procaspase-3 expression in MCF-7 and other drug-resistant breast cancer cells resulted in complete reversal of the drug-resistant phenotype. Thus, the level of procaspase-3 is important for the impact of apoptotic stimuli .
The re-expression of caspase-3 was, however, not sufficient to sensitize the MCF-7 cells to die by apoptosis upon g-irradiation . Thus, both the caspase-3 positive and deficient MCF-7 cells remained equally refractory to irradiation-induced cell death. However, irradiation induced a permanent G2-arrest in MCF-7 cells irrespective of caspase-3 proficiency. This indicates that the DNA damage checkpoint signaling dissociates to mediate arrest and activate apoptosis. Thus, activation of cell cycle arrest programs without triggering apoptosis upon DNA damage could represent a major mechanism leading to radiation resistance in malignant tumors. In fact, we recently found in patients treated with radiochemotherapy prior to tumor surgery that induction of p21 CIP/WAF-1 and a concomittant decrease of proliferative activity identifies patients with a poor prognosis and high risk of early relapse (Rau et al., 2003) . To this end, we functionally dissected the signaling requirements to overcome G2 arrest and activate apoptosis in irradiated MCF-7 cells.
Previous studies suggested that this signaling defect in MCF-7 cells was not due to defects in repair of DNA double-strand breaks upon ionizing irradiation (IR) . Similarly, the capacity to activate cell cycle arrest programs is not disturbed in MCF-7 cells. Thus, the radiation resistance appears to result directly from the failure to trigger the intrinsic death program upon activation of the DNA damage checkpoint. To this end, we show in the present work that the manipulation of the DNA damage checkpoint and G2 arrest by caffeine, a pharmacological inhibitor of the DNA-damage-induced stress response, overcomes the cell cycle arrest and triggers a caspase-3-dependent apoptosis pathway in irradiated, caspase-3-proficient MCF-7 cells. Furthermore, caffeine induced a decrease in p21 CIP/WAF-1 protein levels. In turn, adenoviral. p21 CIP/WAF-1 expression completely abolished sensitization for irradiation-induced apoptosis by caffeine. This links radiation resistance in MCF-7 cells to the failure to undergo cell cycle progression upon IR with p21 CIP/WAF-1 playing a central role. Apart from the dissection of this novel resistance mechanism, we provide a strategy to overcome resistance to irradiation-induced cell death in anticancer therapy.
Results
IR induces cell cycle arrest while chemotherapeutic drugs induce apoptosis through a caspase-3-dependent mechanism MCF-7 breast carcinoma cells are widely used as a model system for breast cancer. Recently, MCF-7 cells were shown to carry a 47-base pair deletion within exon 3 of the CASP-3 gene that results in failure to express the caspase-3 zymogen (Ja¨nicke et al., 1998) . To this end, we demonstrated that the reconstitution of procaspase-3 restores the sensitivity to drug-induced apoptosis not only in the MCF-7 cells but also in other breast cancer cell lines lacking sufficient procaspase-3 expression .
In contrast to anticancer drugs, IR triggers a longterm cell cycle arrest program in the G2 phase of the cell cycle . In contrast to anticancer drugs that trigger apoptosis in caspase-3 reconstituted MCF-7 cells (MCF-7-C3) but not in caspase-3 deficient control transfectants (MCF-7 mock), no such difference was found upon g-irradiation. In both MCF-7 mock and MCF-7-C3, only a small percentage of cells undergoes apoptotic cell death upon IR at doses up to 20 Gy (Figure 1) . In contrast to IR, exposure of the MCF-7 cells with 1 mg/ml epirubicin induced apoptotic DNA fragmentation in 96% of the MCF-7 caspase-3 transfectants as compared with 18% of the caspase-3-deficient vector controls (Figure 1 ). Exposure to epirubicin, but not IR, resulted in processing of caspase-9 to the p37 intermediate and caspase-3 to the active p17 subunit in MCF-7-C3 but not in the caspase-3-deficient MCF-7 mock transfectants (Figure 2 ). In contrast, IR induced a drastic increase in expression of the cyclin-dependent kinase (CDK) inhibitor p21 CIP/WAF-1 whereas p21
CIP/WAF-1 levels were even decreased in epirubicin-treated cells. Thus, MCF-7-C3 cells have the propensity to undergo apoptosis upon DNA damage but are resistant to irradiation-induced apoptosis irrespective of their level of caspase-3 expression. This resistance was also obvious when LDH-release or trypan blue uptake were determined to assess nonapoptotic modes of cell death (data not shown), indicating that MCF-7 cells remain viable following IR. Instead of triggering apoptosis, IR induces a persistent G2 arrest program in MCF-7 cells as characterized by a high expression of cyclin B1, a tetraploid DNA content and lack of signs of mitotic progression such as MPM-2 phosphoepitope exposure (data not shown).
Caffeine induces release from G2 arrest and caspase-3-dependent apoptosis These data suggested that resistance to IR occurs in consequence of DNA-damage-induced cell cycle arrest upon p21 CIP/WAF-1 induction. To test this hypothesis, DNA-damage-induced stress responses were inhibited by the use of caffeine, an inhibitor of ATM/ATR kinase activity (Sarkaria et al., 1999) . This in turn abrogates DNA-damage-induced cell cycle arrest (Zhou et al., 2000) . Apart from its effect on checkpoint kinase signaling, caffeine interferes with ATM-mediated activation of p53 signaling (Kastan and Lim, 2000) . The p53 target gene p21 CIP/WAF-1 does not only mediate cell cycle arrest upon IR (el-Deiry et al., 1993) but is also known to interfere with apoptosis signaling upon DNA damage (Waldman et al., 1996) . The CDK inhibitor p21 CIP/WAF-1 belongs to the CIP/KIP family of CDK inhibitors which, unlike the INK4 family of CDK inhibitors, mediates not only G1 but also G2-arrest (Taylor and Stark, 2001) . To this end, we investigated the effect of caffeine on apoptosis induction in irradiated MCF-7 cells. Coculture of the irradiated cells with caffeine facilitated apoptosis in the caspase-3 reconstituted MCF-7-C3 but not in the caspase-3-negative vector controls ( Figure 3 ). In the MCF-7-C3 cells, 20 Gy g-irradiation induced 17% apoptosis after 72 h, which was increased to 31% apoptosis in the presence of caffeine at 1 mM. In contrast, apoptosis was oberserved in 13% of the MCF-7 mock cells upon irradiation in the absence of caffeine as compared to 11% apoptosis in the caffeine-treated cultures. The caspase-3 dependency of apoptosis upon caffeine-triggered G2 release was confirmed by the use of zDEVD-fmk, an inhibitor of CIP/WAF-1 expression. MCF-7 cells mock transfected with either pcDNA3 (MCF-7 mock; vector control) or pcDNA3-procaspase-3 (MCF-7 C3) were exposed to 20 Gy g-irradiation or the topoisomerase II inhibitor epirubicin at 1 mg/ml and incubated for 24 h. Protein extracts were subjected to Western blot analysis to determine processing of caspase-3 and -9 and induction of the CDK inhibitor p21 CIP/WAF-1 . C: control, EP: epirubicine, IR: ionising irradiation. caspase-3 like enzyme activity. Addition of zDEVD-fmk at 10 mM completely abolished the sensitization for irradiation-induced apoptosis by caffeine in the caspase-3-proficient MCF-7 cells thereby reducing the level of irradiation-induced apoptosis to the level of the caspase-3-negative vector controls ( Figure 4) .
As expected, IR induced p21 CIP/WAF-1 expression in both caspase-3-deficient and -proficient MCF-7 cells (Figure 5a ). Treatment of MCF-7 cells with caffeine at 1 and 2 mM resulted in a decrease of irradiation-induced p21 CIP/WAF-1 protein expression. Likewise, caffeine interfered with p21 CIP/WAF-1 mRNA expression as determined by quantitative real-time PCR that was decreased by approximately 50% upon exposure of irradiated cells to caffeine (Figure 5b ). Inhibition of p21 CIP/WAF-1 protein expression therefore occurs through a transcriptional mechanism and interference of caffeine with p21 CIP/WAF-1 mRNA expression.
p21
Cip/WAF-1 abrogates apoptosis induced upon G2 release Disruption of p21 CIP/WAF-1 expression was shown previously to result in impaired G2 arrest upon DNA damage and to sensitize for DNA-damage-induced apoptosis (Waldman et al., 1996) . To corroborate the functional relevance of caffeine-mediated inhibition of p21 CIP/WAF-1 expression, we re-expressed p21 CIP/WAF-1 in caffeine-treated cells. To this end, we constructed a replication incompetent adenoviral expression vector based on the Ad-Easy system (He et al., 1998) . The resulting Ad-p21 vector contains the human p21 CIP/WAF-1 cDNA under the control of a CMV promoter. Adenoviral expression of p21 CIP/WAF-1 in G2-arrested MCF-7 cells completely abrogated the caffeinemediated sensitization for irradiation-induced apoptosis in caspase-3-proficient MCF-7 cells (Figure 6 ). Irradiation with a single dose of 20 Gy induced 18% apoptotic cell death in MCF-7 caspase-3 transfectants after 72 h incubation. Apoptosis was increased to 31% by 1 mM caffeine. Adenoviral expression of p21 CIP/WAF-1 at 10 (Figure 6a and b) . Thus, p21
CIP/WAF-1 impedes IR-induced cell death and interferes with IR-induced apoptosis indicating that sensitization by caffeine occurs in consequence of impaired DNAdamage-induced p21 CIP/WAF-1 expression and cell cycle arrest.
To validate this model, we tested the impact of p21 CIP/WAF-1 in a second, independent cell system, HCT116 cells, where p21 CIP/WAF-1 was deleted by targeted gene knockout (Waldman et al., 1996) . In contrast to MCF-7, HCT116 cells are per se sensitive to IR-induced apoptosis. IR-induced apoptosis was induced by doses as low as 2 Gy at 72 h after IR and reached a plateau at 20 Gy with 48% of the cells undergoing apoptotic DNA fragmentation (Figure 7a and b) . Loss of p21 CIP/WAF-1 was associated with a significant increase of sensitivity against IR with 90% of the p21 À/À HCT116 cells undergoing apoptosis at 72 h after IR with 20 Gy. Western blot analysis of irradiated HCT116 cells showed processing of caspase-3 to the active p17 subunit 24 h after g-irradiation with 5 or 10 Gy (Figure 7c) .
The caspase-3 dependency of irradiation-induced apoptosis in this model was confirmed by the use of zDEVD-fmk, an inhibitor of caspase-3 like enzyme activity. Addition of zDEVD-fmk at 40 mM abrogates the sensitization for irradiation-induced apoptosis in HCT116 p21
À/À cells thereby reducing the level of irradiation-induced apoptosis from 89 to 62% (Figure  8a and b) .
Discussion
Acquired or constitutive resistance is a major hindrance of cytotoxic anticancer therapies. Both chemotherapeutic drugs and IR induce apoptotic cell death and activate caspases in a variety of cellular systems. Although these cytotoxic therapies head for different primary targets, it has become obvious that in most cases, therapy-induced apoptosis converges on a common pathway, causing mitochondrial membrane permeabilization (Kroemer and Reed, 2000) and subsequent activation of downstream caspases, such as caspase-3. While these apoptotic pathways are now reasonably well understood, the upstream signaling involved in triggering mitochondrial apoptosis signaling and activation of the caspase network remains in large parts enigmatic. This applies especially to the interfaces between DNA-damage recognition, DNA repair, cell cycle arrest and apoptosis signaling.
Dysfunction of apoptotic pathways has been implicated in the development of resistance to therapy. In this line, we recently demonstrated that disruption of caspase-3 processing in vivo is a key feature of therapy-refractory relapse of childhood acute lymphoblastic leukemia (Prokop et al., 2000) . In the same context, we have previously shown that re-expression of proapoptotic regulators, such as Bax (von Haefen et al., , 2004 Gillissen et al., 2003; Prokop et al., 2003) or procaspase-3 (Friedrich et al., 2001 ) restores the sensitivity of cancer cells for drug-induced apoptosis in carcinoma cells with acquired resistance to anticancer therapy.
In addition to apoptosis, DNA damage by IR triggers cell cycle checkpoint control signaling and subsequent cell cycle arrest, augmenting the ability of cells to repair damaged DNA. Such an apoptosis-inhibitory effect was described previously for p53 signaling where disruption 
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CIP/WAF-1 of p53 (Bunz et al., 1998) or the p53 target genes p21 CIP/WAF (Waldman et al., 1996) and 14-3-3s (Chan et al., 1999) facilitated DNA-damage-induced apoptosis. Similarly, loss of p21 primes carcinoma cells for G2 arrest and subsequent apoptosis following expression of the p14 ARF tumor suppressor gene Normand et al., 2005) Checkpoint-triggered cell cycle arrest programs could hence contribute to the development of resistance to anticancer drugs or IR, a formidable limitation in current cancer treatment. In fact, we recently showed that induction of p21 CIP/WAF-1 and slowed down tumor cell proliferation represent a clinically relevant resistance mechanism that results in shorter progression-free survival in colorectal carcinoma treated by radiochemotherapy (Rau et al., 2003) . Consequently, agents that override cell cycle checkpoints could be used to sensitize cells to killing by genotoxic drugs. Such sensitizing effects have been described previously for broad-range kinase inhibitors, for example, caffeine (Zhou et al., 2000) or flavopiridol (Motwani et al., 1999) or staurosporine derivatives (Bhonde et al., 2005) .
To this end, we investigated the signaling requirements for apoptosis induction in MCF-7 cells that have retained the capacity to undergo a sustained cell cycle arrest but fail to undergo apoptosis upon IR . Restoration of procaspase-3 sensitizes for drug-induced apoptosis but, however, not for apoptosis triggered upon DNA damage by IR in MCF-7 cells. Instead of undergoing massive apoptotic DNA fragmentation, procaspase-3 reconstituted MCF-7 cells underwent a tetraploid cell cycle arrest in G2 upon IR and remained viable. Previous experiments demonstrated that MCF-7 cells display an undisturbed propensity to repair DNA damage upon IR . Thus, the upstream signaling, that is, the sensing of radiation-induced DNA damage is intact. Likewise, DNA-damage-induced, cell cycle checkpointtriggered arrest does not appear to be defective. In fact, we show in the present report that the DNA-damageinduced CDK inhibitor p21 CIP/WAF-1 plays a critical role in mediating resistance to irradiation-induced apoptosis in MCF-7 cells. In our present study, disruption of IRinduced cell cycle arrest was achieved by use of the ATM-like kinase inhibitor caffeine. Regarding the mechanism of G2 arrest and apoptosis resistance, caffeine treatment was associated with a decrease in p21 CIP/WAF-1 expression upon IR. Intact p21 CIP/WAF-1 expression was previously implicated in prevention of DNA-damage-induced apoptosis. The targeted knockout of the p21 CIP/WAF-1 gene resulted in sensitization to DNA damage in the HCT116 cell line model. Some previous studies also demonstrated the apoptosissensitizing effect of p21 inactivation (Xaus et al., 1999; Javelaud and Besancon, 2002; Chu et al., 2004) . In accordance with this hypothesis, re-expression of p21 CIP/WAF-1 completely abrogated the sensitizing effect of caffeine on irradiated and cell cycle arrested MCF-7 cells. Here, we demonstrate in two independent systems, MCF-7 and HCT116 cells, that p21 interferes with activation of a caspase-3-dependent apoptotic program by IR. Inhibition of the DNA damage response by caffeine triggered a caspase-3-dependent apoptosis program that could be overcome either by addition of zDEVD-fmk, an inhibitor of caspase-3 like activities or enforced expression of p21 CIP/WAF-1 . Procaspase-3 expression and caspase-3 activation therefore appears to be crucial not only for drug-induced apoptosis but also for apoptosis upon IR and to overcome resistance to irradiation-induced cell death.
Altogether, our data delineate that the decision making for apoptosis induction in MCF-7 cells following IR is intact but cell death execution is hampered due to arrest in the G2 phase of the cell division cycle and loss of caspase-3. In view of our clinical data on the role of p21 in progression-free survival of patients with rectal carcinoma, such a p21-mediated failure to die by apoptosis could well lead to prolonged persistence of viable tumor cells. Albeit stuck in the cell cycle this tumor cell persistence might allow re-entry and clonogeneic growth and explain the poor prognosis of cancer patients who show elevated levels of p21 in residual tumor cells (Rau et al., 2003) .
Our data delineate a cell cycle arrest-and p21-mediated resistance mechanism against IR that occurs through interference with caspase-3 function thereby providing a further link between cell cycle deregulation and apoptosis. Moreover, our findings delineate that cell cycle checkpoint signaling provides a suitable target for therapeutic intervention. Evidence for the usefulness of such a strategy also comes from our recent observation that induction of p21 CIP/WAF-1 during preoperative radiotherapy mediates acquired resistance in rectal carcinoma (Rau et al., 2003) . Such strategies therefore warrant evaluation in a clinical setting.
Materials and methods

Cell culture
Control vector (pcDNA3-transfected) and pcDNA3-caspase-3-transfected MCF-7 Hasenja¨ger et al., 2004) and HCT116 wild-type or p21 À/À cells (Waldman et al., 1996) were grown in RPMI 1640 medium supplemented with 10% fetal calf serum (FCS), 0.56 g/l L-glutamine, 100 U/ml penicillin and 0.1 mg/ml streptomycin (all from GIBCO-BRL, Karlsruhe, Germany) at 371C with 5% CO 2 in a fully humidified atmosphere. Cells were infected with recombinant, replication-deficient adenovirus diluted in cell culture medium in the absence of FCS or antibiotics at the indicated MOI for 1.5 h at 371C or were mock treated with serum-free medium only. Thereafter, equal amounts of medium supplemented with 20% FCS, 200 U/ml penicillin and 0.2 mg/ml streptomycin were added. A Cs-137 g-source was used for IR experiments.
Construction of recombinant adenoviral vectors
The method for production of recombinant, replicationdeficient adenoviral vectors was performed as described earlier (He et al., 1998) and adenoviral plasmids were kindly provided by B Vogelstein (He et al., 1998) . For the construction of Adp21, the p21 cDNA was excised from ATCC clone-p21 as a XhoI/BsrBI fragment and cloned into the shuttle vector pShuttle-CMV XhoI/EcoRV. For construction of Ad-b-gal the full-length b-galactosidase was excised from pbgal-Basic (BD Clontech, Heidelberg, Germany); end filling was made with T4 polymerase and the b-galactosidase fragment was then cloned into the EcoRV linearized shuttle vector pShuttle-CMV. Homologous recombination with the pAdEasy1 vector containing the adenoviral genes deleted in E1 and E3 was performed in the Escherichia coli strain BJ5183 RecBC-sbcB. For the large-scale production of recombinant adenovirus, 10 mg of each adenoviral construct was transfected into HEK293 cells using calcium phosphate/DNA precipitates and adenoviral plaques were propagated according to standard procedures as described (Chartier et al., 1996) .
Antibodies and reagents
Antibody against p21 CIP/WAF-1 (clone 6B6, raised against a fusion protein between GST and full-length human p21) was a murine monoclonal antibody purchased from BD-Pharmingen (Heidelberg, Germany) and used at a dilution of 1:250. Polyclonal anti-human caspase-9 produced in goat was from R&D Systems GmbH and was used at 1:1000. Polyclonal antihuman caspase-3 produced in goat was from R&D Systems GmbH and was used at 1:1000. Polyclonal anti-human actin antibody produced in rabbits was from Sigma-Aldrich, Taufkirchen, Germany and was used at 1:500. All antibodies were diluted in PBS supplemented with 0.05% Tween-20 (PBS-T) containing 3% nonfat dry milk and 0.1% NaN 3 . Secondary goat-anti-mouse IgG and goat-anti-rabbit IgG antisera coupled to horseradish peroxidase (HRP) were from Promega Corporation (Madison, WI, USA) and were used at a dilution of 1:5000 in PBS-T. Caspase-3 inhibitor (z-DEVD-fmk) was from Calbiochem (Bad Soden, Germany). RNase A was from Roth (Karlsruhe, Germany). Epirubicin was purchased from Pharmacia Upjohn (Erlangen, Germany). Caffeine was from Alexis corporation (La¨ufelfingen, Switzerland).
Immunoblotting
After trypsinization, cells were collected by centrifugation at 300 g, 41C for 5 min, washed twice with ice-cold PBS and lysed in appropiate amounts of lysis buffer (10 mM Tris/HCl, pH 7.5, 300 mM NaCl, 1% Triton X-100, 2 mM MgCl 2 , 5mM EDTA) supplemented with protease inhibitors (1 mM pepstatin, 1 mM leupeptin and 0.1 mM phenylmethylsulfonyl fluoride for 30 min on ice). Samples were centrifuged at 10 000 g, 41C for 15 min and the concentration of total cellullar protein was determined from the supernatants using the bicinchoninic acid assay from Pierce (Rockford, IL, USA). Thereafter, samples were mixed with sample buffer (125 mM Tris HCl, 288 mM b-mercaptoethanol, 20% glycerol, 2% SDS, 10 mg/ml bromophenol blue), boiled for 5 min, and equal amounts of protein (20 mg) were separated by SDS-PAGE using 16 or 10% gels, respectively. Immunoblotting was performed as described . Briefly, nitrocellulose membranes (Schleicher & Schuell; Dassel, Germany) were rinsed in transfer buffer (10 mM 3-(cyclohexylamino) propane-1-sulfonic acid, pH 11, 10% methanol for 5 min, and blotting was performed at 1 mA/cm 2 for 1 h in a transblot semidry blot cell (BioRad; Mu¨nchen, Germany). Thereafter, membranes were blocked for 1 h in blocking buffer
